Potential Interplay between Hyperosmolarity and Inflammation on Retinal Pigmented Epithelium in Pathogenesis of Diabetic Retinopathy

被引:42
作者
Willermain, Francois [1 ,2 ]
Scifo, Lisa [1 ,3 ]
Weber, Celia [1 ,3 ]
Caspers, Laure [1 ]
Perret, Jason [3 ]
Delporte, Christine [3 ]
机构
[1] CHU St Pierre & Brugmann, Dept Ophthalmol, B-1000 Brussels, Belgium
[2] Univ Libre Bruxelles, IRIBHM, B-1050 Brussels, Belgium
[3] Univ Libre Bruxelles, Lab Pathophysiol & Nutr Biochem, B-1050 Brussels, Belgium
关键词
diabetic retinopathy; high salt diet; hyperosmolarity; retinal pigmented epithelium; blood retinal barrier; inflammation; ENDOTHELIAL GROWTH-FACTOR; ALDOSE REDUCTASE; SODIUM-CHLORIDE; DIETARY SALT; MACULAR EDEMA; INTRAVITREAL TRIAMCINOLONE; AQUAPORIN EXPRESSION; CELLS INVOLVEMENT; VOLUME REGULATION; GENE-EXPRESSION;
D O I
10.3390/ijms19041056
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Diabetic retinopathy is a frequent eyesight threatening complication of type 1 and type 2 diabetes. Under physiological conditions, the inner and the outer blood-retinal barriers protect the retina by regulating ion, protein, and water flux into and out of the retina. During diabetic retinopathy, many factors, including inflammation, contribute to the rupture of the inner and/or the outer blood-retinal barrier. This rupture leads the development of macular edema, a foremost cause of sight loss among diabetic patients. Under these conditions, it has been speculated that retinal pigmented epithelial cells, that constitute the outer blood-retinal barrier, may be subjected to hyperosmolar stress resulting from different mechanisms. Herein, we review the possible origins and consequences of hyperosmolar stress on retinal pigmented epithelial cells during diabetic retinopathy, with a special focus on the intimate interplay between inflammation and hyperosmolar stress, as well as the current and forthcoming new pharmacotherapies for the treatment of such condition.
引用
收藏
页数:17
相关论文
共 134 条
[21]   Vascular endothelial growth factor and diabetic retinopathy: pathophysiological mechanisms and treatment perspectives [J].
Caldwelll, RB ;
Bartoli, M ;
Behzadian, MA ;
El-Remessy, AEB ;
Al-Shabrawey, M ;
Platt, DH ;
Caldwell, RW .
DIABETES-METABOLISM RESEARCH AND REVIEWS, 2003, 19 (06) :442-455
[22]   Involvement of HMGB1 mediated signalling pathway in diabetic retinopathy: evidence from type 2 diabetic rats and ARPE-19 cells under diabetic condition [J].
Chen, Xiao-Li ;
Zhang, Xue-Dong ;
Li, Ying-Yuan ;
Chen, Xue-Mei ;
Tang, De-Rong ;
Ran, Rui-Jin .
BRITISH JOURNAL OF OPHTHALMOLOGY, 2013, 97 (12) :1598-1603
[23]   Is age-related macular degeneration a manifestation of systemic disease? New prospects for early intervention and treatment [J].
Cheung, C. M. G. ;
Wong, T. Y. .
JOURNAL OF INTERNAL MEDICINE, 2014, 276 (02) :140-153
[24]  
CIVAN MM, 1994, J MEMBRANE BIOL, V139, P1
[25]   Interleukin 6 induces the expression of vascular endothelial growth factor [J].
Cohen, T ;
Nahari, D ;
Cerem, LW ;
Neufeld, G ;
Levi, BZ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (02) :736-741
[26]  
Cunha-Vaz J, 2017, DEV OPHTHALMOL, V58, P11, DOI 10.1159/000455265
[27]   Novel pharmacotherapies in diabetic retinopathy: Current status and what's in the horizon [J].
Das, Arup ;
McGuire, Paul G. ;
Monickaraj, Finny .
INDIAN JOURNAL OF OPHTHALMOLOGY, 2016, 64 (01) :4-13
[28]   Vitreous Mediators in Retinal Hypoxic Diseases [J].
dell'Omo, Roberto ;
Semeraro, Francesco ;
Bamonte, Giulio ;
Cifariello, Francesco ;
Romano, Mario R. ;
Costagliola, Ciro .
MEDIATORS OF INFLAMMATION, 2013, 2013
[29]   Immune regulation in the retina [J].
Detrick, Barbara ;
Hooks, John J. .
IMMUNOLOGIC RESEARCH, 2010, 47 (1-3) :153-161
[30]   Diabetic retinopathy: current understanding, mechanisms, and treatment strategies [J].
Duh, Elia J. ;
Sun, Jennifer K. ;
Stitt, Alan W. .
JCI INSIGHT, 2017, 2 (14)